Oculis
ID: 7646310Oculis is a biopharmaceutical platform for ophthalmic and neuro-ophthalmic diseases founded in 2017 by Einar Stefansson.
4
Funding Rounds
$129.5m
Money raised
Recent Funding Rounds
Overview
Oculis is a biopharmaceutical platform for ophthalmic and neuro-ophthalmic diseases founded in 2017 by Einar Stefansson.
- Website:
- Headquarters: Reykjavík
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ei*** St******** |
|
- | |
| Th******** Lo****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Oculis has raised a total of $253.5m in funding over 4 rounds.
Key Insights:
- Oculis Debt Funding Round, August 2025: $124m
- Oculis Series C round, May 2021: $57m
- Oculis May 2021 Series C Funding Round: $57m
- Oculis Series B round, January 2018: $15.5m
Industries
Oculis is active in the following industries: